HALO logo
halo search icon
Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated
LGND · NAS

Ligand Pharmaceuticals Incorporated

US$217.75

Price Arrow9.97 (4.80%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapHALO AllHALO MomentumHALO MQV
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Ligand Pharmaceuticals Incorporated Overview

LGND Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Strong

Garp

Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Weak

About LGND

icon

Telephone

1.858.550.7500

icon

Address

Suite 200, 555 Heritage Drive, Jupiter, FL 33458

Description

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

LGND Price Chart

Key Stats

Market Cap

US$4.16B

PE

30.80

EV/EBITDA

43.9

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 98.89 - 247.38

Trade Value (12mth)

US$9,479,657.00

1 week

-2.55%

1 month

-8.33%

YTD

9.29%

1 year

102.81%

All time high

247.38

Key Fundamentals

EPS 3 yr Growth

-425.40%

EBITDA Margin

30.20%

Operating Cashflow

$49m

Free Cash Flow Return

4.30%

ROIC

10.80%

Interest Coverage

17.20

Quick Ratio

22.00

Other Data

Shares Outstanding (Fully Diluted)

20m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

LGND Announcements

Latest Announcements

DateAnnouncements
18 May 26
18 May 26
09 May 26
09 May 26
07 May 26

LGND Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock3.02-0.226.44locklocklock
EPS (Fully Diluted)
$locklocklocklock2.94-0.226.13locklocklock
Growth
%locklocklocklock252.4-107.33,020.0locklocklock
PE
Xlocklocklocklock24.3N/A30.8locklocklock
EV/EBITDA
Xlocklocklocklock23.228.243.9locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Ligand Pharmaceuticals Incorporated (LGND:NAS)?
Halo FAQ
The current share price of Ligand Pharmaceuticals Incorporated (LGND:NAS) is USD$217.75.
What is the 52-week high share price for Ligand Pharmaceuticals Incorporated (LGND:NAS)?
Halo FAQ
The 52-week high share price for Ligand Pharmaceuticals Incorporated (LGND:NAS) is USD$247.38.
What is the 52-week low share price for Ligand Pharmaceuticals Incorporated (LGND:NAS)?
Halo FAQ
The 52-week low share price for Ligand Pharmaceuticals Incorporated (LGND:NAS) is USD$98.89.
What is the dividend yield for Ligand Pharmaceuticals Incorporated (LGND:NAS)?
Halo FAQ
Ligand Pharmaceuticals Incorporated (LGND:NAS) does not pay a dividend.
What was Ligand Pharmaceuticals Incorporated (LGND:NAS) last dividend payment?
Halo FAQ
The last dividend payment of Ligand Pharmaceuticals Incorporated (LGND:NAS) is USD$2.50.
What is the franking level for Ligand Pharmaceuticals Incorporated (LGND:NAS)?
Halo FAQ
Ligand Pharmaceuticals Incorporated (LGND:NAS) has a franking level of 0.00%.
In which sector is Ligand Pharmaceuticals Incorporated (LGND:NAS) classified?
Halo FAQ
Ligand Pharmaceuticals Incorporated (LGND:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Ligand Pharmaceuticals Incorporated (LGND:NAS)?
Halo FAQ
The current P/E ratio for Ligand Pharmaceuticals Incorporated (LGND:NAS) is 30.80.

See beyond the curve.

One solution for research, investing and portfolio management.